Our lab specializes in the design, synthesis, and characterization of synthetic and natural hydrogel biomaterials for soft tissue engineering and drug delivery applications. More recently, we have focused on the biotherapeutic field by designing 3-dimensional (3D) physiologically relevant non-animal models (NAMs) and drug screening platforms. Such platforms are acutely pertinent in biomedical research due to a shift in the focus of the National Institutes of Health away from animal models and towards human-based research technologies, including 3D tissue culture. In this talk, I will present hydrogel, microgel and cryogel scaffolds for cell encapsulation, devices and techniques for microgel fabrication, as well as microfluidic devices to introduce perfusion to bioengineered tissues that our lab has developed. In our work, we have prioritized mild chemistries that allow in situ cell encapsulation as well as approaches amenable to semi-high-throughput processing and data analysis to enable drug screening applications. As specific example applications, I will discuss hydrogel-based in vitro models for studying tumor spheroid growth and chemotherapeutic responses at interfaces of varying stiffness and biochemical composition, with focus on glioblastoma and hepatocellular carcinoma. The examples will showcase custom polyethylene glycol scaffolds decorated with degradable and adhesive moieties or blended with gelatin and hyaluronic acid-based polymers to guide cell behaviors.